Rapid Diagnostic Testing for Malaria Case Management

Rapid diagnostic tests (RDTs) for malaria have transformed the approach to febrile illness by enabling prompt, point-of-care detection of Plasmodium antigens without the need for microscopy. These lateral-flow immunochromatographic assays deliver qualitative or semi-quantitative results within 15–20 minutes, facilitating immediate clinical decisions. Deployment of RDTs supports the World Health Organization’s “test and treat” strategy, which emphasises parasitological confirmation of malaria prior to antimalarial therapy. This approach reduces unnecessary drug use, curbs selection pressure for drug-resistant parasites and promotes differential diagnosis of non-malarial fevers. RDTs have been integrated across public clinics, community health worker programmes and, increasingly, private retail outlets. Advances in test sensitivity and heat stability, coupled with streamlined supply-chain management, have expanded access in remote and resource-limited settings. Nonetheless, challenges remain in ensuring consistent test quality, adherence to results by health workers and patients, and integration with surveillance and antibiotic stewardship efforts. Continuous innovation in test formats, multiplex platforms and digital result reporting promises further gains in case management and in the broader goal of malaria elimination.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Rapid Diagnostic Testing for Malaria Case Management publication trend

The graph below shows the total number of articles in rapid diagnostic testing for malaria case management across all publications each year (not limited to Nature Index journals).

Technical terms

Rapid Diagnostic Test (RDT): A lateral-flow immunochromatographic assay that detects malaria antigens in a small blood sample, providing qualitative results within minutes without specialised laboratory equipment.

Parasitological confirmation: Verification of malaria infection through detection of parasites or parasite antigens, typically by microscopy or RDT, in contrast to presumptive clinical diagnosis based on symptoms alone.

Sensitivity: The ability of a diagnostic test to correctly identify individuals who have malaria (true-positive rate), crucial for minimising missed cases.

Specificity: The ability of a diagnostic test to correctly identify individuals who do not have malaria (true-negative rate), important for reducing overtreatment.

References

1. Malaria rapid diagnostic tests in community pharmacies in Rwanda: availability, knowledge of community pharmacists, advantages, and disadvantages of licensing their use. Global Health Research and Policy (2023).
2. Cost-effectiveness of sentinel screening of endemic diseases alongside malaria diagnosis: A case study in schistosomiasis. PLOS Neglected Tropical Diseases (2024).
3. Private sector antimalarial sales a decade after “test and treat”: A cross-sectional study of drug shop clients in rural Uganda. Frontiers in Public Health (2023).